CCL18 (Protein|Antibody|cDNA Clone|ELISA Kit)

All CCL18 reagents are produced in house and quality controlled, including 4 CCL18 Antibody, 13 CCL18 Gene, 1 CCL18 Protein, 1 CCL18 qPCR. All CCL18 reagents are ready to use.

Recombinant CCL18 proteins are expressed by Yeast with fusion tags as C-His.

CCL18 antibodies are validated with different applications, which are ELISA, IHC-P.

CCL18 cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each CCL18 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

CCL18 Protein (1)

Species

CCL18 Protein, Human, Recombinant (His Tag)

10502-H08Y

Expression host: Yeast

Human CCL18 / PARC / MIP-4 Protein 8871
Go

CCL18 Antibody (4)

Application Clonality
Host

Anti-CCL18 Antibody

10502-RP01

Specificity: Human

Application: ELISA

Clonality: PAb

Anti-CCL18 Antibody

10502-T16

Specificity: Human

Application: ELISA,IHC-P

Clonality: PAb

Human CCL18 / PARC / MIP-4 Immunohistochemistry(IHC) 4593

Anti-CCL18 Antibody

10502-MM07

Specificity: Human

Application: ELISA

Clonality: MAb

Anti-CCL18 Antibody

10502-R016

Specificity: Human

Application: ELISA

Clonality: MAb

Go

CCL18 cDNA Clone (13)

Human

CCL18 qPCR Primer (1)

CCL18 is a chemotactic cytokine involved in the pathogenesis and progression of various disorders, including cancer. Proof showed high levels of CCL18 in the serum of epithelial ovarian carcinoma patients suggesting its potential as a circulating biomarker. CCL18 chemokine has an important role in chemokine-mediated tumor metastasis, and may serve as a potential predictor for poor survival outcomes for ovarian cancer. (CCL18) is predominantly secreted by M2-tumor associated macrophages (TAMs) and promotes malignant behaviors of various human cancer types. CCL18 has a correlation with cardiac function in patients with AAMI and it might be considered as an indicator of poor LVEF in patients with AAMI. Circulating and WAT-secreted CCL18 correlates with insulin resistance and metabolic risk score. Because CCL18 is macrophage-specific and associates with adipose immune gene expression, it may constitute a marker of WAT inflammation. Macrophages are thought to be the main source of CCL18, and the effect of pirfenidone, an anti-fibrotic agent for idiopathic pulmonary fibrosis, on the expression of CCL18 in macrophages warrants investigation.
Protein
Antibody
Gene
qPCR
Close